Literature DB >> 30372592

The national landscape of deceased donor kidney transplantation for the highly sensitized: Transplant rates, waitlist mortality, and posttransplant survival under KAS.

Kyle R Jackson1, Karina Covarrubias1, Courtenay M Holscher1, Xun Luo1, Jennifer Chen1, Allan B Massie1,2, Niraj Desai1, Daniel C Brennan3, Dorry L Segev1,2,4, Jacqueline Garonzik-Wang1.   

Abstract

Deceased donor kidney transplantation (DDKT) rates for highly sensitized (HS) candidates increased early after implementation of the Kidney Allocation System (KAS) in 2014. However, this may represent a bolus effect, and a granular investigation of the current state of DDKT for HS candidates remains lacking. We studied 270 722 DDKT candidates from the SRTR from 12/4/2011 to 12/3/2014 ("pre-KAS") and 12/4/2014 to 12/3/2017 ("post-KAS"), analyzing DDKT rates for HS candidates using adjusted negative binomial regression. Post-KAS, candidates with the highest levels of sensitization had an increased DDKT rate compared with pre-KAS (cPRA 98% adjusted incidence rate ratio [aIRR]:1.27 1.772.46 P = .001, cPRA 99% aIRR:3.18 4.365.98 P < .001, cPRA 99.5-99.9% aIRR:16.91 24.2934.89 P < .001, and cPRA 99.9%+ aIRR:8.79 11.5815.26 P < .001). To determine whether these changes produced more equitable access to DDKT, we compared DDKT rates of HS to non-HS candidates (cPRA 0-79%). Post-KAS, cPRA, 98% candidates had an equivalent DDKT rate (aIRR:0.65 0.941.36 , P = .8) to non-HS candidates, whereas 99% candidates had a higher DDKT rate (aIRR:1.19 1.682.38 , P = .02). Although cPRA 99.5-99.9% candidates had an increased DDKT rate (aIRR:2.46 3.504.98 , P < .001) compared to non-HS candidates, cPRA 99.9%+ candidates had a significantly lower DDKT rate (aIRR:0.29 0.400.56 , P < .001). KAS has improved access to DDKT for HS candidates, although substantial imbalance exists between cPRA 99.5-99.9% and 99.9%+ candidates.
© 2018 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; health services and outcomes research; kidney transplantation/nephrology; organ allocation; organ procurement and allocation; panel-reactive antibody (PRA); sensitization

Mesh:

Year:  2018        PMID: 30372592      PMCID: PMC6433516          DOI: 10.1111/ajt.15149

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  33 in total

1.  A note on robust variance estimation for cluster-correlated data.

Authors:  R L Williams
Journal:  Biometrics       Date:  2000-06       Impact factor: 2.571

2.  Effective communication of standard errors and confidence intervals.

Authors:  Thomas A Louis; Scott L Zeger
Journal:  Biostatistics       Date:  2008-06-10       Impact factor: 5.899

3.  Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation.

Authors:  Robert A Montgomery; Andrea A Zachary; Lloyd E Ratner; Dorry L Segev; Janet M Hiller; Julie Houp; Mathew Cooper; Louis Kavoussi; Thomas Jarrett; James Burdick; Warren R Maley; J Keith Melancon; Tomasz Kozlowski; Christopher E Simpkins; Melissa Phillips; Amol Desai; Vanessa Collins; Brigitte Reeb; Edward Kraus; Hamid Rabb; Mary S Leffell; Daniel S Warren
Journal:  JAMA       Date:  2005-10-05       Impact factor: 56.272

4.  New priorities: Analysis of the New Kidney Allocation System on UCLA patients transplanted from the deceased donor waitlist.

Authors:  Michelle J Hickey; Ying Zheng; Nicole Valenzuela; Qiuheng Zhang; Carolyn Krystal; Erik Lum; Eileen W Tsai; Gerald S Lipshutz; H Albin Gritsch; Gabriel Danovitch; Jeffrey Veale; David Gjertson; Michael Cecka; Elaine F Reed
Journal:  Hum Immunol       Date:  2016-11-03       Impact factor: 2.850

Review 5.  Kidney transplantation of highly sensitized recipients under the new kidney allocation system: A reflection from five different transplant centers across the United States.

Authors:  Ronald F Parsons; Jayme E Locke; Robert R Redfield; Garrett R Roll; Matthew H Levine
Journal:  Hum Immunol       Date:  2016-10-20       Impact factor: 2.850

6.  Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.

Authors:  Elisabeth Schwaiger; Farsad Eskandary; Nicolas Kozakowski; Gregor Bond; Željko Kikić; Daniel Yoo; Susanne Rasoul-Rockenschaub; Rainer Oberbauer; Georg A Böhmig
Journal:  Nephrol Dial Transplant       Date:  2016-03-24       Impact factor: 5.992

7.  Probability of deceased donor kidney transplantation based on % PRA.

Authors:  I C Bostock; J Alberú; A Arvizu; E A Hernández-Mendez; A De-Santiago; N González-Tableros; M López; N Castelán; A G Contreras; L E Morales-Buenrostro; B Gabilondo; M Vilatobá
Journal:  Transpl Immunol       Date:  2013-05-16       Impact factor: 1.708

8.  Early Changes in Kidney Distribution under the New Allocation System.

Authors:  Allan B Massie; Xun Luo; Bonnie E Lonze; Niraj M Desai; Adam W Bingaman; Matthew Cooper; Dorry L Segev
Journal:  J Am Soc Nephrol       Date:  2015-12-17       Impact factor: 10.121

9.  New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes.

Authors:  Ajay K Israni; Nicholas Salkowski; Sally Gustafson; Jon J Snyder; John J Friedewald; Richard N Formica; Xinyue Wang; Eugene Shteyn; Wida Cherikh; Darren Stewart; Ciara J Samana; Adrine Chung; Allyson Hart; Bertram L Kasiske
Journal:  J Am Soc Nephrol       Date:  2014-05-15       Impact factor: 10.121

10.  Post-listing survival for highly sensitised patients on the UK kidney transplant waiting list: a matched cohort analysis.

Authors:  Miriam Manook; Leonardo Koeser; Zubir Ahmed; Matthew Robb; Rachel Johnson; Olivia Shaw; Nicos Kessaris; Anthony Dorling; Nizam Mamode
Journal:  Lancet       Date:  2017-01-06       Impact factor: 79.321

View more
  13 in total

1.  Clinical and Public Policy Implications of Pre-Formed DSA and Transplant Outcomes.

Authors:  Edmund Huang; Stanley C Jordan
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-18       Impact factor: 8.237

2.  Association between Allosensitization and Waiting List Outcomes among Adult Lung Transplant Candidates in the United States.

Authors:  Laneshia K Tague; Chad A Witt; Derek E Byers; Roger D Yusen; Patrick R Aguilar; Hrishikesh S Kulkarni; Karen Bennett Bain; Keith A Fester; Varun Puri; Daniel Kreisel; Thalachallour Mohanakumar; Elbert P Trulock; Ramsey R Hachem
Journal:  Ann Am Thorac Soc       Date:  2019-07

Review 3.  Principles of Virtual Crossmatch Testing for Kidney Transplantation.

Authors:  Madhu C Bhaskaran; Sebastiaan Heidt; Thangamani Muthukumar
Journal:  Kidney Int Rep       Date:  2022-03-15

4.  Alloimmune Risk Stratification for Kidney Transplant Rejection.

Authors:  Oriol Bestard; Olivier Thaunat; Maria Irene Bellini; Georg A Böhmig; Klemens Budde; Frans Claas; Lionel Couzi; Lucrezia Furian; Uwe Heemann; Nizam Mamode; Rainer Oberbauer; Liset Pengel; Stefan Schneeberger; Maarten Naesens
Journal:  Transpl Int       Date:  2022-05-20       Impact factor: 3.842

Review 5.  Clinical Pig Kidney Xenotransplantation: How Close Are We?

Authors:  David K C Cooper; Hidetaka Hara; Hayato Iwase; Takayuki Yamamoto; Abhijit Jagdale; Vineeta Kumar; Roslyn Bernstein Mannon; Michael J Hanaway; Douglas J Anderson; Devin E Eckhoff
Journal:  J Am Soc Nephrol       Date:  2019-12-02       Impact factor: 10.121

6.  Posttransplant Outcomes for cPRA-100% Recipients Under the New Kidney Allocation System.

Authors:  Kyle R Jackson; Courtenay Holscher; Jennifer D Motter; Niraj Desai; Allan B Massie; Jacqueline Garonzik-Wang; Nada Alachkar; Dorry L Segev
Journal:  Transplantation       Date:  2020-07       Impact factor: 5.385

7.  How do highly sensitized patients get kidney transplants in the United States? Trends over the last decade.

Authors:  Kyle R Jackson; Jennifer D Motter; Amber Kernodle; Niraj Desai; Alvin G Thomas; Allan B Massie; Jacqueline M Garonzik-Wang; Dorry L Segev
Journal:  Am J Transplant       Date:  2020-03-12       Impact factor: 8.086

Review 8.  Highly Sensitized Patients Are Well Served by Receiving a Compatible Organ Offer Based on Acceptable Mismatches.

Authors:  Sebastiaan Heidt; Geert W Haasnoot; Marissa J H van der Linden-van Oevelen; Frans H J Claas
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

9.  Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients.

Authors:  Christian Kjellman; Angela Q Maldonado; Kristoffer Sjöholm; Bonnie E Lonze; Robert A Montgomery; Anna Runström; Tomas Lorant; Niraj M Desai; Christophe Legendre; Torbjörn Lundgren; Bengt von Zur Mühlen; Ashley A Vo; Håkan Olsson; Stanley C Jordan
Journal:  Am J Transplant       Date:  2021-07-19       Impact factor: 9.369

10.  Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes).

Authors:  Stanley C Jordan; Christophe Legendre; Niraj M Desai; Tomas Lorant; Mats Bengtsson; Bonnie E Lonze; Ashley A Vo; Anna Runström; Lena Laxmyr; Kristoffer Sjöholm; Åsa Schiött; Elisabeth Sonesson; Kathryn Wood; Lena Winstedt; Christian Kjellman; Robert A Montgomery
Journal:  Transplantation       Date:  2021-08-01       Impact factor: 5.385

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.